Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Bone Marrow Transplantation

• Publication date

  1999-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.bmt.1701798PMID 10414908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD34 counts to predict the adequate collection of peripheral blood progenitor cells

  1997cited by this paper
• Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma.

  1997cited by this paper
• The biology and clinical uses of blood stem cells.

  1997cited by this paper
• Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.

  1997cited by this paper
• Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer.

  1996cited by this paper
• Patient Condition Affects the Collection of Peripheral Blood Progenitors After Priming with Recombinant Granulocyte Colony-Stimulating Factor

  1995cited by this paper
• Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.

  1995cited by this paper
• Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.

  1995cited by this paper
• Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.

  1995cited by this paper
• Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization.

  1995cited by this paper
• An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy.

  1995cited by this paper
• Large‐volume leukapheresis for collection of mononuclear cells for hematopoietic rescue in Hodgkin's disease

  1995cited by this paper
• Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF.

  1995cited by this paper
• Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma.

  1994cited by this paper
• Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.

  1993cited by this paper
• Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy.

  1993cited by this paper
• Hematopoietic growth factors and human megakaryocyte differentiation.

  1992cited by this paper
• Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors.

  1992cited by this paper
• Defining a Therapeutic Dose of Peripheral Blood Stem Cells

  1992cited by this paper
• Large‐volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies

  1992cited by this paper
• Autotransplantation of peripheral blood stem cells mobilized by chemotherapy and recombinant human granulocyte colony‐stimulating factor in childhood neuroblastoma and non‐Hodgkin's lymphoma

  1992cited by this paper
• Mini‐BEAM followed by BEAM and ABMT for very poor risk Hodgkin's disease

  1992cited by this paper
• Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.

  1991cited by this paper
• Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor.

  1990cited by this paper
• Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis

  1989cited by this paper
• Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients.

  1988cited by this paper
• GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN

  1988cited by this paper
• Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.

  1983cited by this paper
• Selection and interpretation of diagnostic tests and procedures. Principles and applications.

  1981cited by this paper
• Use of relative operating characteristic analysis in epidemiology. A method for dealing with subjective judgement.

  1981cited by this paper
• Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood

  1978cited by this paper
• Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood.

  1978cited by this paper

• Impact of apheresis automation on procedure quality and predictability of CD34+ cell yield

  2018cites this paper
• Large volume leukapheresis is efficient and safe even in small children up to 15 kg body weight.

  2017cites this paper
• Cyclophosphamide plus granulocyte‐colony stimulating factor for hematopoietic stem cell mobilization in patients with multiple myeloma

  2016cites this paper
• Development of model for analysing respective collections of intended hematopoietic stem cells and harvests of unintended mature cells in apheresis for autologous hematopoietic stem cell collection.

  2014cites this paper
• Cells for Tissue Engineering

  2014cites this paper
• Large volume leukapheresis: Efficacy and safety of processing patient's total blood volume six times.

  2011cites this paper
• Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF.

  2006cites this paper
• Prediction of target CD34 positive cells following leukopheresis in children with neuroblastoma

  2006cites this paper
• Progenitor cell recruitment during individualized high‐flow, very‐large‐volume apheresis for autologous transplantation improves collection efficiency

  2006cites this paper
• Progenitor cell mobilisation in patients with acute and chronic coronary artery disease

  2006cites this paper
• Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSF

  2005cites this paper
• Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells.

  2004cites this paper
• Factors affecting the efficacy of peripheral blood progenitor cells collections by large‐volume leukaphereses with standardized processing volumes

  2004cites this paper
• Evaluation of clinical and biological parameters useful for predicting the extent of progenitor cell mobilisation and long- term engraftment in transplanted onco-haematological patients

  2003cites this paper
• HPC enumeration with the Sysmex XE-2100 can guide further flow cytometric CD34(+) measurements and timing of leukaphereses.

  2003cites this paper
• The absolute number of peripheral blood CD34+ cells predicts a timing for apheresis and progenitor cell yield in patients with hematologic malignancies and solid tumors.

  2003cites this paper
• Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients.

  2002cites this paper
• Fludarabine , araC , novantrone and dexamethasone ( FAND ) in previously treated chronic lymphocytic leukemia patients

  2002cites this paper
• CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G–CSF

  2001cites this paper
• Determination of peripheral blood stem cells by the Sysmex SE-9500.

  2001cites this paper
• Kinetic studies during peripheral blood stem cell collection show CD34+ cell recruitment intra‐apheresis

  2001cites this paper
• High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34+ PBSC in patients undergoing high-dose chemotherapy and stem cell rescue.

  2000cites this paper
• CD34+ cells during leukapheresis procedures: relationship of volume processed and quantity of peripheral blood progenitor cells collected

  2000cites this paper
• Rapid Communication High Steady-State Plasma Levels of flt3-Ligand in the Peripheral Blood Is a Good Predictor for Poor Mobilization of CD34 1 PBSC in Patients Undergoing High-Dose Chemotherapy and Stem Cell Rescue

  year unknowncites this paper